Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

61. EANM-EAN recommendations for the use of brain 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in neurodegenerative cognitive impairment and dementia: Delphi consensus Full Text available with Trip Pro

EANM-EAN recommendations for the use of brain 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in neurodegenerative cognitive impairment and dementia: Delphi consensus European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus - Nobili - 2018 - European Journal of Neurology - Wiley Online Library Search (...) within Search term Search term The full text of this article hosted at iucr.org is unavailable due to technical difficulties. EAN Guidelines/CME Article Free Access European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus Corresponding Author E-mail address: Department of Neuroscience (DINOGMI), University of Genoa

2018 European Academy of Neurology

62. Dementia

Dementia Evidence Maps - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history

2018 Trip Evidence Maps

63. Dementia: assessment, management and support for people living with dementia and their carers

Dementia: assessment, management and support for people living with dementia and their carers Dementia: assessment, management and Dementia: assessment, management and support for people living with dementia support for people living with dementia and their carers and their carers NICE guideline Published: 20 June 2018 nice.org.uk/guidance/ng97 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility (...) , to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Dementia: assessment, management and support for people living with dementia and their carers

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

64. Evaluating the effect of Brainfood groups for people with mild cognitive impairment and mild dementia: preliminary mixed-methodology study Full Text available with Trip Pro

Evaluating the effect of Brainfood groups for people with mild cognitive impairment and mild dementia: preliminary mixed-methodology study Brainfood is a 5-week group intervention for people with mild cognitive impairment and mild dementia, promoting cognitive health through a Mediterranean-style diet, exercise, mindfulness and health self-management.To evaluate Brainfood acceptability and the feasibility of conducting a randomised controlled trial; in a single group study in two National

2018 BJPsych open Controlled trial quality: uncertain

65. Socioeconomic status, gender and dementia: The influence of work environment exposures and their interactions with APOE ɛ4 Full Text available with Trip Pro

Socioeconomic status, gender and dementia: The influence of work environment exposures and their interactions with APOE É›4 It is a well-established fact that unfavourable social and economic conditions have a negative impact on health and longevity. Recent findings suggest that this is also true of age-related dementias. Yet most common indicators of socioeconomic status (SES) say very little about the actual mechanisms at play in disease development. The present paper explores five work (...) exposure characteristics, all of which have a clear social gradient, that could potentially shed further light on the relationship between SES and dementia. Specifically, it investigates whether these exposures could moderate the impact of a well-known genetic risk factor: the APOE ɛ4 allele. The empirical analyses are based on data from a Swedish population study (n = 1019). Main occupation was linked to The Job Exposure Matrix to estimate the individuals' exposure to the following work environment

2018 SSM - population health

66. Taking the responsibility in dementia care: A concept analysis about facticity Full Text available with Trip Pro

Taking the responsibility in dementia care: A concept analysis about facticity The aim of this study is to develop a comprehensive definition of facticity, applicable to dementia nursing.Walker and Avant's Concept Analysis was used to analyse facticity. Published literature found in PubMed, CINAHL, PsycInfo, and Scopus using the search term facticity and nursing, as well as books and dictionaries and empirical data was used to clarify the concept.Facticity in nursing dementia care is being

2018 Nursing open

67. Agitation and Aggression in Long-Term Care Residents with Dementia

Agitation and Aggression in Long-Term Care Residents with Dementia 2018 EVIDENCE UPDATE Managing Agitation and Aggression in Long-Term Care Residents with Dementia 1 2018 Evidence Update: Managing Agitation and Aggression in Long-Term Care Residents with Dementia Pablo Navarro, Stephen Bornstein 2018 EVIDENCE UPDATE Managing Agitation and Aggression in Long-Term Care Residents with Dementia 2 Table of Contents Background 3 Research Question for this Synthesis 4 Results 4 Overview 5 Findings (...) : Interventions Studied in Original Report 5 Music Therapy 6 Staff Training 7 Person Centered Care 7 Person-Centered Bathing 7 Dementia-Care Mapping 8 Emotion-Oriented Care 8 Reducing the Use of Anti-Psychotic Medications 8 Animal-Assisted Therapy 9 Aromatherapy 9 Dance Therapy 9 Pain Treatment 9 Personalized Activities 9 Simulated Family Presence 10 Special Care Units 10 Staff Case Conferences 10 Findings: Interventions Not Reviewed in the Original Report 10 Electro Stimulation 10 Enhancing Family Visits 10

2018 Newfoundland and Labrador Centre for Health Information

68. Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial. Full Text available with Trip Pro

Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial. To estimate the effect of a moderate to high intensity aerobic and strength exercise training programme on cognitive impairment and other outcomes in people with mild to moderate dementia.Multicentre, pragmatic, investigator masked, randomised controlled trial.National Health Service primary care, community and memory services, dementia research (...) registers, and voluntary sector providers in 15 English regions.494 people with dementia: 329 were assigned to an aerobic and strength exercise programme and 165 were assigned to usual care. Random allocation was 2:1 in favour of the exercise arm.Usual care plus four months of supervised exercise and support for ongoing physical activity, or usual care only. Interventions were delivered in community gym facilities and NHS premises.The primary outcome was score on the Alzheimer's disease assessment scale

2018 BMJ Controlled trial quality: predicted high

69. An Assistive Technology System that Provides Personalized Dressing Support for People Living with Dementia: Capability Study Full Text available with Trip Pro

An Assistive Technology System that Provides Personalized Dressing Support for People Living with Dementia: Capability Study Individuals living with advancing stages of dementia (persons with dementia, PWDs) or other cognitive disorders do not have the luxury of remembering how to perform basic day-to-day activities, which in turn makes them increasingly dependent on the assistance of caregivers. Dressing is one of the most common and stressful activities provided by caregivers because of its

2018 JMIR medical informatics

70. Identifying Performance Measures, Indicators and Targets to Monitor and Evaluate Dementia Strategies

Identifying Performance Measures, Indicators and Targets to Monitor and Evaluate Dementia Strategies The image part with relationship ID rId9 was not found in the file. Rapid Synthesis Identifying Performance Measures, Indicators and Targets to Monitor and Evaluate Dementia Strategies 6 April 2018 McMaster Health Forum 1 Evidence >> Insight >> Action Rapid Synthesis: Identifying Performance Measures, Indicators and Targets to Monitor and Evaluate Dementia Strategies Three-day response 6 April (...) 2018 Identifying Performance Measures, Indicators and Targets to Monitor and Evaluate Dementia Strategies 2 Evidence >> Insight >> Action McMaster Health Forum The McMaster Health Forum’s goal is to generate action on the pressing health-system issues of our time, based on the best available research evidence and systematically elicited citizen values and stakeholder insights. We aim to strengthen health systems – locally, nationally, and internationally – and get the right programs, services

2018 McMaster Health Forum

71. Anticholinergic drugs and risk of dementia: case-control study. Full Text available with Trip Pro

Anticholinergic drugs and risk of dementia: case-control study. To estimate the association between the duration and level of exposure to different classes of anticholinergic drugs and subsequent incident dementia.Case-control study.General practices in the UK contributing to the Clinical Practice Research Datalink.40 770 patients aged 65-99 with a diagnosis of dementia between April 2006 and July 2015, and 283 933 controls without dementia.Daily defined doses of anticholinergic drugs coded (...) using the Anticholinergic Cognitive Burden (ACB) scale, in total and grouped by subclass, prescribed 4-20 years before a diagnosis of dementia.Odds ratios for incident dementia, adjusted for a range of demographic and health related covariates.14 453 (35%) cases and 86 403 (30%) controls were prescribed at least one anticholinergic drug with an ACB score of 3 (definite anticholinergic activity) during the exposure period. The adjusted odds ratio for any anticholinergic drug with an ACB score of 3

2018 BMJ

72. Diagnostic accuracy of Instrumental Activities of Daily Living for dementia in community-dwelling older adults Full Text available with Trip Pro

Diagnostic accuracy of Instrumental Activities of Daily Living for dementia in community-dwelling older adults many people living with dementia remain underdiagnosed and unrecognised. Screening strategies are important for early detection.to examine whether the Lawton's Instrumental Activities of Daily Living (IADL) scale, compared with other cognitive screening tools-the Mini-Mental State Examination (MMSE), and the Ascertain Dementia 8-item Informant Questionnaire (AD8)-can identify older (...) (≥ 65 years) adults with dementia.population-based cross-sectional observational study.all 19 counties in Taiwan.community-dwelling older adults (n = 10,340; mean age 74.87 ± 6.03).all participants underwent a structured in-person interview. Dementia was identified using National Institute on Aging-Alzheimer's Association core clinical criteria for all-cause dementia. Receiver operator characteristic curves were used to determine the discriminant abilities of the IADL scale, MMSE and AD8

2018 EvidenceUpdates

73. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Full Text available with Trip Pro

Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Antipsychotic agents are often used to treat neuropsychiatric symptoms (NPS) in people with dementia although there is uncertainty about the effectiveness of their long-term use for this indication and concern that they may cause harm, including higher mortality. When behavioural strategies have failed and treatment with antipsychotic drugs is instituted (...) , regular attempts to withdraw them have been recommended in guidelines. Physicians, nurses and families of older people with dementia may be reluctant to stop antipsychotics, fearing deterioration of NPS.This is an update of a Cochrane Review published in 2013.To evaluate whether withdrawal of antipsychotic agents is successful in older people with dementia and NPS in primary care or nursing home settings, to list the different strategies for withdrawal of antipsychotic agents in older participants

2018 Cochrane

74. Living condition, weight loss and cognitive decline among people with dementia Full Text available with Trip Pro

Living condition, weight loss and cognitive decline among people with dementia The aim of this study was to investigate cognitive performance and BMI of patients with dementia living in their own homes with family members, nursing homes and alone.A prospective observational cohort study with a quantitative design.Mini-mental state examination (MMSE) scores and BMI were examined with a sample of Slovak patients (N = 428). Patients were followed up 12 months later after the first (...) examination.Cognitive decline was significantly faster for patients living in nursing homes and for solitary patients. BMI consistently decreased in the follow-up examination and this drop was stronger in patients living alone and in nursing homes. Patients with VaD manifested a stronger BMI decline as compared with AD patients. This study suggests that impoverished conditions such as nursing homes or social isolation of solitary people contribute to stronger progress in dementia. Healthcare professionals need

2018 Nursing open

75. Astrocyte dysfunction following molybdenum-associated purine loading could initiate Parkinson’s disease with dementia Full Text available with Trip Pro

Astrocyte dysfunction following molybdenum-associated purine loading could initiate Parkinson’s disease with dementia Sporadic or idiopathic Parkinson's disease is a movement disorder with a worldwide distribution, a long pre-clinical latent period and a frequent association with dementia. The combination of molybdenum deficiency and purine ingestion could explain the movement disorder, the distribution, the latent period and the dementia association. Recent studies in sheep have shown (...) receptors in the nigro-striatum. This could result in Parkinson's disease. Guanosine ingestion in molybdenum-deficient humans will lead to guanosine loading and potentially a disturbance to the guanosine receptors in the hippocampus, amygdala and ventral striatum. This could result in dementia. The molybdenum content of the average daily diet in the United States is 0.07 ppm and in the United Kingdom 0.04 ppm. Central nervous system disease occurs in sheep at <0.04 ppm. Consistent with the role proposed

2018 NPJ Parkinson's disease

76. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. Full Text available with Trip Pro

Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. Alzheimer's disease and other forms of dementia are becoming increasingly common with the aging of most populations. The majority of individuals with dementia will first present for care and assessment in primary care settings. There is a need for brief dementia screening instruments that can accurately diagnose dementia in primary care settings. The Mini-Cog is a brief, cognitive (...) screening test that is frequently used to evaluate cognition in older adults in various settings.To determine the diagnostic accuracy of the Mini-Cog for diagnosing Alzheimer's disease dementia and related dementias in a primary care setting.We searched the Cochrane Dementia and Cognitive Improvement Register of Diagnostic Test Accuracy Studies, MEDLINE, Embase and four other databases, initially to September 2012. Since then, four updates to the search were performed using the same search methods

2018 Cochrane

77. ACHIEVING A PEACEFUL DEATH: What We've Learned in 30 Years, Including Dementia

ACHIEVING A PEACEFUL DEATH: What We've Learned in 30 Years, Including Dementia I not a bot. Resume. Are you not a robot? Click on the button to continue: I not a bot. Resume.

2018 MedicalVideos

78. Diagnosis of dementia in the elderly with PTSD

Diagnosis of dementia in the elderly with PTSD Diagnosis of dementia in the elderly with PTSD We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Swedish Agency for Health Technology Assessment and Assessment of Social Services Diagnosis of dementia in the elderly with PTSD Share: Reading time less than 1 minute Some of the symptoms of posttraumatic stress disorder (PTSD) remind of the symptoms of early development of dementia (...) . This can make it difficult with an assessment tool to clearly see if a person diagnosed with PTSD has started to develop dementia. Question Is there scientific evidence for any assessment tool that can identify development of dementia in the elderly with PTSD? SBU Enquiry Service consists of systematic literature searches to highlight studies that can address questions received by the SBU Enquiry Service from Swedish healthcare or social service providers. Relevant references are compiled by an SBU

2018 Swedish Council on Technology Assessement

79. Effects of Cognitive Training on Cognition and Quality of Life of Older Persons with Dementia (Abstract)

Effects of Cognitive Training on Cognition and Quality of Life of Older Persons with Dementia To evaluate the effect of cognitive training on cognition and health-related quality of life (HRQoL) in community-dwelling persons with dementia.Single-blind randomized controlled trial with 3- and 9-month follow-up.Adult day care centers in Helsinki, Finland.Older individuals with mild to moderate dementia living at home and attending adult day care twice a week (N = 147; mean age 83, 72% female, 63 (...) % at mild stage of dementia).A systematic 12-week training program focused on subskills of executive function: attention, working memory, cognitive flexibility, and planning. The intervention group (n = 76) underwent cognitive training twice a week for 45 minutes, and the control group (n = 71) attended day care as usual.Primary outcomes were the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) for global cognition and the 15-dimensional instrument (15D) for HRQoL. The outcomes were

2018 EvidenceUpdates

80. What is desirable care in the opinion of formal and informal caregivers in nursing‐home care for patients with dementia? Full Text available with Trip Pro

What is desirable care in the opinion of formal and informal caregivers in nursing‐home care for patients with dementia? To examine care characteristics related to desirable care as reported by formal and informal caregivers in Dutch Psycho-geriatric nursing homes for patients with dementia.Qualitative exploratory study.The sample consisted of four nursing homes. In each home, semi-structured interviews were conducted with a manager, a quality advisor or head nurse, a daily care supervisor

2018 Nursing open